DeepX Health is pleased to announce that the DermoSight Teledermatology Solution is now in use in a primary care setting, as a new pilot has been setup in a collaboration between DeepX Health Ltd and the NHS. The DermoSight platform was initiated in an existing NHS Primary Care teledermatology service following disruption and delays due to COVID-19. Within the first month of implementation benefits were realised when compared to the current system with regards to:
- Ease of use and efficiency with administrative time saved
- Consistent quality of images and no rejected consultations
- Improvements in the recording, reporting and advice received
A decision to expand the service to other high output sites was made and implemented after the first 3-month trial.